Specific Biologics is developing a platform gene editing technology for potential therapeutics. Dualase is designed to overcome two problems with existing gene editing technologies – random DNA insertions / deletions and low frequency of DNA repair. Dualase cuts DNA twice leaving non-compatible ends which creates precision length deletions to disrupt genes or increases the frequency of repair to correct genes. 

Specific Biologics Logo



Event details

Date: June 8 - 12, 2020

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


34 in total